Scott Olsen

Title: Scott Olsen: Innovator in Pharmaceutical Chemistry

Introduction

Scott Olsen is a notable inventor based in San Diego, California. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. His work focuses on creating innovative solutions to treat various diseases and disorders.

Latest Patents

Scott Olsen holds a patent for Azole-fused pyridazin-3(2H)-one derivatives. This patent discloses compounds of Formula (1) and pharmaceutically acceptable salts thereof, wherein α, β, n, R, R, R, R, R, R, R, X, X, X, and X are defined in the specification. The disclosure also relates to materials and methods for preparing these compounds, as well as pharmaceutical compositions comprising them. These compounds are particularly useful for treating diseases, disorders, and conditions associated with GPR139. He has 1 patent to his name.

Career Highlights

Scott Olsen is currently employed at Takeda Pharmaceutical Company Limited, where he continues to advance his research and development efforts. His work at Takeda has allowed him to collaborate with other talented professionals in the field.

Collaborations

Some of his notable coworkers include Holger Monenschein and Sean Timothy Murphy. Their combined expertise contributes to the innovative projects at Takeda.

Conclusion

Scott Olsen's contributions to pharmaceutical chemistry exemplify the impact of innovation in medicine. His work on Azole-fused pyridazin-3(2H)-one derivatives showcases his commitment to developing effective treatments for complex health issues.